Exact Mass: 428.2223576
Exact Mass Matches: 428.2223576
Found 500 metabolites which its exact mass value is equals to given mass value 428.2223576,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Irbesartan
Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2774 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
Austalide L
Austalide L is a mycotoxin produced by Aspergillus ustu
Taraxacolide 1-O-b-D-glucopyranoside
*Constituent of Taraxacum officinale (dandelion). Taraxacolide 1-O-b-D-glucopyranoside is found in many foods, some of which are coffee and coffee products, beverages, alcoholic beverages, and tea. Taraxacolide 1-O-b-D-glucopyranoside is found in alcoholic beverages. *Taraxacolide 1-O-b-D-glucopyranoside is a constituent of Taraxacum officinale (dandelion
Bedoradrine
Falipamil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Lotrafiban
Xanthine amine congener
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
Hypochoeroside A
Hypochoeroside a belongs to germacranolides and derivatives class of compounds. Those are sesquiterpene lactones with a structure based on the germacranolide skeleton, characterized by a gamma lactone fused to a 1,7-dimethylcyclodec-1-ene moiety. Hypochoeroside a is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Hypochoeroside a can be found in endive, which makes hypochoeroside a a potential biomarker for the consumption of this food product.
Sphaeranthanolide
Sonchuside F
Sonchuside G
11beta,13-dihydroparthenolide-14-O-beta-D-glucopyranoside
(E,E)-3beta-O-beta-D-glucopyranosyl-9beta-hydroxy-6beta,7alpha,11betaH-germacra-1(10),4-dien-12,6-olide|scorzoaustriacoside
4alpha,5alpha-epoxy-10alpha,11beta,13H,14H-1-epi-inuviscolide 3-beta-D-glucoside
(5-angeloyloxytiglinoyloxy)-costunolide|<5-angeloyloxytiglinoyloxy>-costunolide
3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-
13,14-dihydroxy-15,16 dimethoxy-(-)-6alpha-hydroxy-5alpha,8alpha,9alpha,10alpha-cleroda-3-en-18-oic acid
(1R,2S,4S,5R,6R,9S)-2-hydroxy-11-oxoallocedra-13-oic acid 13-O-beta-D-glucopyranosyl ester
14-O-beta-D-glucopyranosyl-6-deoxy-3,4-dehydrofloridanolide|dunnianolide A
1-(2-Amino-1-oxopropyl)-2,3,3alpha, 13alpha, 14,15,16,18alpha-octahydro-8-methoxy-5,9-metheno-9H-dipyrrolo[3,2-b:1,2-e][1,5,8]oxadiazacyclopentadecine-13,18-(1H,12H)-dione
3,4-dimethoxy-benzoic acid 11-oxo-dodecahydro-7,14-methano-dipyrido[1,2-a;1,2-e][1,5]diazocin-2-yl ester|Cineverin|Cineverin (13-Veratroyloxy-lupanin)
1beta-[(E-p-methoxycinnamoyl)oxy]-6alpha-hydroxyisodrimeninol
4alpha-hydroxy-5alpha,8betaH-eudesman-7(11)-en-8alpha,12-olide-15-O-beta-D-glucopyranoside|sarcaglaboside H
5beta,11-dihydroxy-iphionan-4-one-11-O-(alpha-xylopyranoside-2-O-acetate)|5beta,11-dihydroxy-iphionan-4-one-11-O-
3beta-hydroxy-4aH-3-dihydrosantamarine-1beta-D-glucopyranoside
4,5-dioxo-seco-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|4,5-dioxo-seco-gamma-eudesmol-
CAY10594
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
irbesartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1074 CONFIDENCE standard compound; INTERNAL_ID 2094 CONFIDENCE standard compound; INTERNAL_ID 8187 Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
Irbesartan (Avapro)
Irbesartan. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=138402-11-6 (retrieved 2024-07-09) (CAS RN: 138402-11-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].
(2R,2R,4aS,6R,8aS)-6,7-diformyl-4-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalen]-6-yl acetate
((S)-2-((E)-6-((R)-3,3-dimethyloxiran-2-yl)-4-methylhex-3-en-1-yl)-8-formyl-5-hydroxy-2-methyl-2H-chromen-7-yl)methyl acetate
Ala Glu Ile Pro
C19H32N4O7 (428.22708819999997)
Ala Glu Leu Pro
C19H32N4O7 (428.22708819999997)
Ala Glu Pro Ile
C19H32N4O7 (428.22708819999997)
Ala Glu Pro Leu
C19H32N4O7 (428.22708819999997)
Ala Ile Glu Pro
C19H32N4O7 (428.22708819999997)
Ala Ile Pro Glu
C19H32N4O7 (428.22708819999997)
Ala Lys Asn Pro
C18H32N6O6 (428.23832120000003)
Ala Lys Pro Asn
C18H32N6O6 (428.23832120000003)
Ala Leu Glu Pro
C19H32N4O7 (428.22708819999997)
Ala Leu Pro Glu
C19H32N4O7 (428.22708819999997)
Ala Asn Lys Pro
C18H32N6O6 (428.23832120000003)
Ala Asn Pro Lys
C18H32N6O6 (428.23832120000003)
Ala Pro Glu Ile
C19H32N4O7 (428.22708819999997)
Ala Pro Glu Leu
C19H32N4O7 (428.22708819999997)
Ala Pro Ile Glu
C19H32N4O7 (428.22708819999997)
Ala Pro Lys Asn
C18H32N6O6 (428.23832120000003)
Ala Pro Leu Glu
C19H32N4O7 (428.22708819999997)
Ala Pro Asn Lys
C18H32N6O6 (428.23832120000003)
Cys Ile Pro Pro
Cys Leu Pro Pro
Cys Pro Ile Pro
Cys Pro Leu Pro
Cys Pro Pro Ile
Cys Pro Pro Leu
Asp Pro Val Val
C19H32N4O7 (428.22708819999997)
Asp Val Pro Val
C19H32N4O7 (428.22708819999997)
Asp Val Val Pro
C19H32N4O7 (428.22708819999997)
Glu Ala Ile Pro
C19H32N4O7 (428.22708819999997)
Glu Ala Leu Pro
C19H32N4O7 (428.22708819999997)
Glu Ala Pro Ile
C19H32N4O7 (428.22708819999997)
Glu Ala Pro Leu
C19H32N4O7 (428.22708819999997)
Glu Ile Ala Pro
C19H32N4O7 (428.22708819999997)
Glu Ile Pro Ala
C19H32N4O7 (428.22708819999997)
Glu Leu Ala Pro
C19H32N4O7 (428.22708819999997)
Glu Leu Pro Ala
C19H32N4O7 (428.22708819999997)
Glu Pro Ala Ile
C19H32N4O7 (428.22708819999997)
Glu Pro Ala Leu
C19H32N4O7 (428.22708819999997)
Glu Pro Ile Ala
C19H32N4O7 (428.22708819999997)
Glu Pro Leu Ala
C19H32N4O7 (428.22708819999997)
Gly Lys Pro Gln
C18H32N6O6 (428.23832120000003)
Gly Lys Gln Pro
C18H32N6O6 (428.23832120000003)
Gly Pro Lys Gln
C18H32N6O6 (428.23832120000003)
Gly Pro Gln Lys
C18H32N6O6 (428.23832120000003)
Gly Gln Lys Pro
C18H32N6O6 (428.23832120000003)
Gly Gln Pro Lys
C18H32N6O6 (428.23832120000003)
Gly Gln Gln Pro
His Ala Thr Thr
His Ser Ser Val
His Ser Val Ser
His Thr Ala Thr
His Thr Thr Ala
His Val Ser Ser
Ile Ala Glu Pro
C19H32N4O7 (428.22708819999997)
Ile Ala Pro Glu
C19H32N4O7 (428.22708819999997)
Ile Cys Pro Pro
Ile Glu Ala Pro
C19H32N4O7 (428.22708819999997)
Ile Glu Pro Ala
C19H32N4O7 (428.22708819999997)
Ile Pro Ala Glu
C19H32N4O7 (428.22708819999997)
Ile Pro Cys Pro
Ile Pro Glu Ala
C19H32N4O7 (428.22708819999997)
Ile Pro Pro Cys
Lys Ala Asn Pro
C18H32N6O6 (428.23832120000003)
Lys Ala Pro Asn
C18H32N6O6 (428.23832120000003)
Lys Gly Pro Gln
C18H32N6O6 (428.23832120000003)
Lys Gly Gln Pro
C18H32N6O6 (428.23832120000003)
Lys Asn Ala Pro
C18H32N6O6 (428.23832120000003)
Lys Asn Pro Ala
C18H32N6O6 (428.23832120000003)
Lys Pro Ala Asn
C18H32N6O6 (428.23832120000003)
Lys Pro Gly Gln
C18H32N6O6 (428.23832120000003)
Lys Pro Asn Ala
C18H32N6O6 (428.23832120000003)
Lys Pro Gln Gly
C18H32N6O6 (428.23832120000003)
Lys Gln Gly Pro
C18H32N6O6 (428.23832120000003)
Lys Gln Pro Gly
C18H32N6O6 (428.23832120000003)
Leu Ala Glu Pro
C19H32N4O7 (428.22708819999997)
Leu Ala Pro Glu
C19H32N4O7 (428.22708819999997)
Leu Cys Pro Pro
Leu Glu Ala Pro
C19H32N4O7 (428.22708819999997)
Leu Glu Pro Ala
C19H32N4O7 (428.22708819999997)
Leu Pro Ala Glu
C19H32N4O7 (428.22708819999997)
Leu Pro Cys Pro
Leu Pro Glu Ala
C19H32N4O7 (428.22708819999997)
Leu Pro Pro Cys
Asn Ala Lys Pro
C18H32N6O6 (428.23832120000003)
Asn Ala Pro Lys
C18H32N6O6 (428.23832120000003)
Asn Ala Pro Gln
Asn Ala Gln Pro
Asn Lys Ala Pro
C18H32N6O6 (428.23832120000003)
Asn Lys Pro Ala
C18H32N6O6 (428.23832120000003)
Asn Pro Ala Lys
C18H32N6O6 (428.23832120000003)
Asn Pro Ala Gln
Asn Pro Lys Ala
C18H32N6O6 (428.23832120000003)
Asn Pro Gln Ala
Asn Gln Ala Pro
Asn Gln Pro Ala
Pro Ala Glu Ile
C19H32N4O7 (428.22708819999997)
Pro Ala Glu Leu
C19H32N4O7 (428.22708819999997)
Pro Ala Ile Glu
C19H32N4O7 (428.22708819999997)
Pro Ala Lys Asn
C18H32N6O6 (428.23832120000003)
Pro Ala Leu Glu
C19H32N4O7 (428.22708819999997)
Pro Ala Asn Lys
C18H32N6O6 (428.23832120000003)
Pro Ala Asn Gln
Pro Ala Gln Asn
Pro Cys Ile Pro
Pro Cys Leu Pro
Pro Cys Pro Ile
Pro Cys Pro Leu
Pro Asp Val Val
C19H32N4O7 (428.22708819999997)
Pro Glu Ala Ile
C19H32N4O7 (428.22708819999997)
Pro Glu Ala Leu
C19H32N4O7 (428.22708819999997)
Pro Glu Ile Ala
C19H32N4O7 (428.22708819999997)
Pro Glu Leu Ala
C19H32N4O7 (428.22708819999997)
Pro Gly Lys Gln
C18H32N6O6 (428.23832120000003)
Pro Gly Gln Lys
C18H32N6O6 (428.23832120000003)
Pro Gly Gln Gln
Pro Ile Ala Glu
C19H32N4O7 (428.22708819999997)
Pro Ile Cys Pro
Pro Ile Glu Ala
C19H32N4O7 (428.22708819999997)
Pro Ile Pro Cys
Pro Lys Ala Asn
C18H32N6O6 (428.23832120000003)
Pro Lys Gly Gln
C18H32N6O6 (428.23832120000003)
Pro Lys Asn Ala
C18H32N6O6 (428.23832120000003)
Pro Lys Gln Gly
C18H32N6O6 (428.23832120000003)
Pro Leu Ala Glu
C19H32N4O7 (428.22708819999997)
Pro Leu Cys Pro
Pro Leu Glu Ala
C19H32N4O7 (428.22708819999997)
Pro Leu Pro Cys
Pro Asn Ala Lys
C18H32N6O6 (428.23832120000003)
Pro Asn Ala Gln
Pro Asn Lys Ala
C18H32N6O6 (428.23832120000003)
Pro Asn Gln Ala
Pro Pro Cys Ile
Pro Pro Cys Leu
Pro Pro Ile Cys
Pro Pro Leu Cys
Pro Gln Ala Asn
Pro Gln Gly Lys
C18H32N6O6 (428.23832120000003)
Pro Gln Gly Gln
Pro Gln Lys Gly
C18H32N6O6 (428.23832120000003)
Pro Gln Asn Ala
Pro Gln Gln Gly
Pro Val Asp Val
C19H32N4O7 (428.22708819999997)
Pro Val Val Asp
C19H32N4O7 (428.22708819999997)
Gln Ala Asn Pro
Gln Ala Pro Asn
Gln Gly Lys Pro
C18H32N6O6 (428.23832120000003)
Gln Gly Pro Lys
C18H32N6O6 (428.23832120000003)
Gln Gly Pro Gln
Gln Gly Gln Pro
Gln Lys Gly Pro
C18H32N6O6 (428.23832120000003)
Gln Lys Pro Gly
C18H32N6O6 (428.23832120000003)
Gln Asn Ala Pro
Gln Asn Pro Ala
Gln Pro Ala Asn
Gln Pro Gly Lys
C18H32N6O6 (428.23832120000003)
Gln Pro Gly Gln
Gln Pro Lys Gly
C18H32N6O6 (428.23832120000003)
Gln Pro Asn Ala
Gln Pro Gln Gly
Gln Gln Gly Pro
Gln Gln Pro Gly
Ser His Ser Val
Ser His Val Ser
Ser Ser His Val
Ser Ser Val His
Ser Val His Ser
Ser Val Ser His
Val Asp Pro Val
C19H32N4O7 (428.22708819999997)
Val Asp Val Pro
C19H32N4O7 (428.22708819999997)
Val Pro Asp Val
C19H32N4O7 (428.22708819999997)
Val Pro Val Asp
C19H32N4O7 (428.22708819999997)
Val Val Asp Pro
C19H32N4O7 (428.22708819999997)
Val Val Pro Asp
C19H32N4O7 (428.22708819999997)
ZK118182 isopropyl ester
C23H37ClO5 (428.23293820000004)
Austalide L
Taraxacolide 1-O-b-D-glucopyranoside
9beta-hydroxy-11beta,13-dihydro-parthenolide-9-O-beta-D-glucopyranoside
9alpha-hydroxy-11beta,13-dihydro-parthenolide-9-O-beta-D-glucopyranoside
1H-Azepine,hexahydro-1-[[[1-[2-(4-methyl-1-piperidinyl)-2-oxoethyl]-1H-benzimidazol-2-yl]thio]acetyl]-(9CI)
Pregna-1,4-dien-21-al, 16,17-[butylidenebis(oxy)]-11-hydroxy-3,20-dioxo-, (11β,16α)
2,2-azobis[2-[1-(2-hydroxyethyl)-2-imidazolin-2-yl]propane] dihydrochloride monohydrate
C16H34Cl2N6O3 (428.20693140000003)
Bedoradrine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
1H-Benzimidazole-1-acetamide,N-cyclopentyl-2-[[2-(2,6-dimethyl-1-piperidinyl)-2-oxoethyl]thio]-(9CI)
HEXOCYCLIUM METHYLSULFATE
C21H36N2O5S (428.23448060000004)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
9-Cyclopentyl-6-[2-(3-imidazol-1-YL-propoxy)-phenylamino]-9H-purine-2-carbonitrile
C23H24N8O (428.20729739999996)
N~2~-[(Benzyloxy)carbonyl]-N-[(1S,2S)-2-hydroxy-1-(4-hydroxybenzyl)propyl]-L-leucinamide
N-[2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl]naphthalene-2-carboxamide
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor both in vitro (IC50=140 nM) and in cells (IC50=110 nM)[1]. CAY10594 strongly inhibits the invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis[2].
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate
C18H37O9P (428.21750820000005)
2-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]-oxomethyl]-1,5-dimethyl-4-pyrrolo[3,2-c]quinolinone
N-(3-fluoro-4-methylphenyl)-4-[3-(4-methyl-1-piperidinyl)propylamino]-3-nitrobenzamide
3-[[cyclopentyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-8-methyl-1H-quinolin-2-one
[(2S,3R)-6-(1,3-benzodioxol-5-ylmethyl)-3-phenyl-1-(phenylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
C27H28N2O3 (428.20998180000004)
N-(cyclohexylmethyl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-[(1R,3S,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-(cyclohexylmethyl)-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-(cyclohexylmethyl)-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
1-[(3aS,4R,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
C27H28N2O3 (428.20998180000004)
(1R)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C27H28N2O3 (428.20998180000004)
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C27H28N2O3 (428.20998180000004)
N-(cyclohexylmethyl)-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
N-(cyclohexylmethyl)-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(1-methyl-4-imidazolyl)sulfonylamino]-2-oxanyl]acetamide
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclopentylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
1-[(3aR,4S,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
C27H28N2O3 (428.20998180000004)
1-[(3aR,4R,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
C27H28N2O3 (428.20998180000004)
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
C27H28N2O3 (428.20998180000004)
(1S)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C27H28N2O3 (428.20998180000004)
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C27H28N2O3 (428.20998180000004)
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C27H28N2O3 (428.20998180000004)
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-(phenylmethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C27H28N2O3 (428.20998180000004)
2-[[(2R)-2-(8-carboxyoctanoyloxy)-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C17H35NO9P+ (428.20493300000004)
2-[[(2R)-3-(8-carboxyoctanoyloxy)-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C17H35NO9P+ (428.20493300000004)
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] dodecanoate
C18H37O9P (428.21750820000005)
1-dodecanoyl-glycero-3-phospho-(1-sn-glycerol)
C18H37O9P (428.21750820000005)
Zaldaride
C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
3,4a,5-trimethyl-6-[(2-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
(4ar,5r,8ar,9as)-5-hydroxy-3,8a-dimethyl-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4h,4ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2-one
(2s,3r,4s,5r)-4,5-dihydroxy-2-({2-[(1r,4r)-4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate
2-(3,4-dimethylpent-3-en-1-yl)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboximidic acid
(1s,2r,4r,7z,11s,12s)-4,12-dimethyl-8-({[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-13-one
(3s,3as,9r,11as)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(3s,3ar,4ar,5s,6r,7ar,9ar)-5-hydroxy-3,5,8-trimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,4ah,6h,7h,7ah,9ah-azuleno[6,5-b]furan-2-one
(3s,3as,5ar,6r,9s,9as,9bs)-3,5a,9-trimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-naphtho[1,2-b]furan-2,8-dione
(3s,3as,9s,11ar)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
19-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
(3s,3ar,4s,6s,7r,7as)-6-ethenyl-4-hydroxy-3,6-dimethyl-7-[(1e)-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl]-hexahydro-1-benzofuran-2-one
3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
3,5a-dimethyl-2-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydronaphtho[1,2-b]furan-9-carbaldehyde
2-{[2-(3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
(1r,3s,4r,6s,7s,8s,9s,10r,13s,14s,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
9-(hydroxymethyl)-5a-methyl-3-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-2-one
20-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
5,9a-dihydroxy-5b,9,9,11a-tetramethyl-2-(penta-1,3-dien-1-yl)-5,5a,6,7,10,11-hexahydro-1,12-dioxatetraphene-4,8-dione
(3s,3as,9s,11as)-6-(hydroxymethyl)-3,10-dimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
6-ethenyl-4-hydroxy-3,6-dimethyl-7-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}prop-1-en-2-yl)-hexahydro-1-benzofuran-2-one
2-(2-hydroxy-1-methoxy-5,6-dimethylhept-5-en-2-yl)-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-2,3-dihydro-1h-indole-5-carboximidic acid
(4s,4ar,5r,6s,8as)-3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl (2z)-2-methylbut-2-enoate
2-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-1h,2h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}propanoic acid
(2s,3r,4s,5r)-2-({2-[(3r,3ar,5r,7as)-3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate
4,5-dihydroxy-2-({2-[4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate
10-({4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoic acid
(3s,3ar,4s,6ar,8s,9s,9ar,9br)-4-hydroxy-3,9-dimethyl-6-methylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydroazuleno[4,5-b]furan-2-one
20r,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003438","Ingredient_name": "20r,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7189","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20s,21-epoxyresibufogenin 3-formate
{"Ingredient_id": "HBIN003472","Ingredient_name": "20s,21-epoxyresibufogenin 3-formate","Alias": "NA","Ingredient_formula": "C25H32O6","Ingredient_Smile": "CC12CCC(CC1CCC3C2CCC4(C35C(O5)CC4C67C=CC(=O)OC6O7)C)OC=O","Ingredient_weight": "428.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7190","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101244896","DrugBank_id": "NA"}
(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16s)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
6-(hydroxymethyl)-3,10-dimethyl-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(5as,7ar,9s,11as,11br)-3,4-diformyl-1-hydroxy-5a,8,8,11a-tetramethyl-6,7,7a,9,10,11,11b,12-octahydro-5-oxatetraphen-9-yl acetate
10-methoxy-1,4,14,19,19-pentamethyl-2,7,18-trioxapentacyclo[11.9.0.0³,¹¹.0⁵,⁹.0¹⁴,²⁰]docosa-3,5(9),10-triene-8,17-dione
2-[(2r,7s,8r,8ar)-7-{[(2e,4e,6s)-4,6-dimethylocta-2,4-dienoyl]oxy}-2-hydroxy-8,8a-dimethyl-3-oxo-7,8-dihydro-1h-naphthalen-2-yl]prop-2-enoic acid
(3as,5ar,6r,8s,9r,9as,9bs)-8-hydroxy-5a,9-dimethyl-3-methylidene-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-2-one
(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16s)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate
(1s,13r,14r,19s)-19-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
(3as,5ar,6r,9r,9as,9bs)-9-(hydroxymethyl)-5a-methyl-3-methylidene-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-2-one
(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
5'-(furan-3-yl)-5,7a,7b-trimethyl-2'-oxo-hexahydro-1ah-spiro[naphtho[1,2-b]oxirene-4,3'-oxolan]-7-yl 2-methylbut-2-enoate
(1r,2s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-2,4,6,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
(4s,4ar,5r,6s,8as)-3,4a,5-trimethyl-6-[(3-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 3-methylbut-2-enoate
5,5,10,13,15-pentamethyl-6,19,22-trioxahexacyclo[13.7.1.0¹,¹¹.0⁴,¹⁰.0¹³,²¹.0¹⁷,²¹]tricos-8-ene-7,14,18-trione
2-{2,5-dihydroxy-4-methyl-3-[(2-methylbut-2-enoyl)oxy]phenyl}-6-methylhepta-1,5-dien-3-yl 2-methylbut-2-enoate
3-[5-(3-formyl-2,6-dihydroxy-4-methylphenyl)-3-methylpenta-1,3-dien-1-yl]-2,3,4-trimethyl-5-oxocyclohexyl acetate
(1s,13r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
(1s,4r,10s,11s,13r,15r,17s)-5,5,10,13,15-pentamethyl-6,19,22-trioxahexacyclo[13.7.1.0¹,¹¹.0⁴,¹⁰.0¹³,²¹.0¹⁷,²¹]tricos-8-ene-7,14,18-trione
3,4a,5-trimethyl-6-[(2-methylbut-2-enoyl)oxy]-9-oxo-4h,5h,6h,7h,8h,8ah-naphtho[2,3-b]furan-4-yl 2-methylbut-2-enoate
(3r,3ar,4s,11ar)-4-hydroxy-3,6,10-trimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
3,4-diformyl-1-hydroxy-5a,8,8,11a-tetramethyl-6,7,7a,9,10,11,11b,12-octahydro-5-oxatetraphen-9-yl acetate
[(1s,2r,5r,6r,7r,8r,11r)-6-[(acetyloxy)methyl]-5,7,11-trihydroxy-2,7-dimethyl-10-oxo-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-6-yl]methyl butanoate
(2r)-2-[(2s)-2-hydroxy-1-methoxy-5,6-dimethylhept-5-en-2-yl]-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-2,3-dihydro-1h-indole-5-carboximidic acid
(3s,3ar,4s,9r,11ar)-4-hydroxy-3,6,10-trimethyl-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
2-[(1s,2r,5r,7s,8s,11s,12r)-7-(acetyloxy)-2,8,11-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid
2-methyl-6-(5-methyl-6-oxo-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}pyran-2-yl)hexyl acetate
(3r,6r,8r,11s,16as)-11-benzyl-9-hydroxy-3,6,8-trimethyl-3h,4h,5h,6h,8h,11h,14h,15h,16h,16ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclotetradecane-1,7,12-trione
3-({6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl}oxy)-2-ethylidene-3-oxopropyl 2-methylbut-2-enoate
2-[(1s,2r,5r,7s,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid
(3s,3ar,5ar,8s,9bs)-3a-hydroxy-3,5a,9-trimethyl-8-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,7h,8h,9bh-naphtho[1,2-b]furan-2-one
(5r,5as,5br,9as,11ar)-5,9a-dihydroxy-5b,9,9,11a-tetramethyl-2-[(1e,3e)-penta-1,3-dien-1-yl]-5,5a,6,7,10,11-hexahydro-1,12-dioxatetraphene-4,8-dione
(1r,3r)-11,14-dihydroxy-16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10,12,14-triene-21-carbonitrile
(3s,4r,5s)-5-[(3e)-4,8-dimethyl-6-oxonona-3,7-dien-1-yl]-3-(2-hydroxy-4-methoxybenzoyl)-4,5-dimethyloxolan-2-one
1-hydroxy-5,5,8a-trimethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,6,7,8-tetrahydro-4h-naphthalene-1,2-dicarbaldehyde
(1s,4r,9r,10s,12r,14s,15r,16r,20r)-15-hydroxy-12-(hydroxymethyl)-5,5,9,14-tetramethyl-18-oxahexacyclo[12.6.1.0¹,¹⁰.0⁴,⁹.0¹²,²⁰.0¹⁶,²⁰]henicos-7-ene-6,13,17-trione
(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16s)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
(3s,3ar,4s,7s,11as)-4-hydroxy-3,6,10-trimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-2-one
4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate
2-methyl-6-{5-methyl-6-oxo-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]pyran-2-yl}hexyl acetate
5-hydroxy-3,8a-dimethyl-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-4h,4ah,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-2-one
(2r,3r)-2-(3,4-dimethylpent-3-en-1-yl)-3-hydroxy-n-(2-hydroxy-5-oxocyclopent-1-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboximidic acid
(1s,2s,5s,6r,7r,8s,9r,12r)-5,8-bis(acetyloxy)-2,7-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-12-yl acetate
(3r,3ar,4s,9s,11as)-4-hydroxy-3,6,10-trimethyl-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
(2s,3r,4s,5r)-2-({2-[(3s,3as,5r,7as)-3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate
(2r,4s,5r,6s)-6-[(1s,9s,12s,19s)-12-ethyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-8-yl]-2,4,5-trihydroxyoxan-3-one
9-methyl-3,6-dimethylidene-2h,3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-(hydroxymethyl)-4-[(2-methylbut-2-enoyl)oxy]but-2-enoate
(3s,3ar,4s,9r,11ar)-4-hydroxy-3,6,10-trimethyl-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
11-benzyl-9-hydroxy-3,6,8-trimethyl-3h,4h,5h,6h,8h,11h,14h,15h,16h,16ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclotetradecane-1,7,12-trione
9-isopropyl-4,4,6,6,12,12,14,14-octamethyl-8,10-dioxatetracyclo[7.7.0.0²,⁷.0¹¹,¹⁶]hexadeca-2(7),11(16)-diene-3,5,13,15-tetrone
10,15-dihydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-triene-8,19-dione
{6-[(acetyloxy)methyl]-5,7,11-trihydroxy-2,7-dimethyl-10-oxo-9-oxatricyclo[6.3.1.0¹,⁵]dodecan-6-yl}methyl butanoate
2-{[2-(3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate
(1s,13r,14s,19r,20r)-20-hydroxy-10-methoxy-1,4,14,18,18-pentamethyl-2,7-dioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-3,5(9),10-triene-8,17-dione
(2's,3'as,4's)-4'-hydroxy-2'-(hydroxymethyl)-2',4',6'-trimethyl-7'-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3'a,7'a-dihydro-1'h-spiro[cyclopropane-1,5'-inden]-3'-one
7-formyl-4,6'-dihydroxy-5',5',8'a-trimethyl-2'-methylidene-3',4',4'a,6',7',8'-hexahydro-3h-spiro[1-benzofuran-2,1'-naphthalen]-6-ylmethyl acetate
(3r,3as,5s,6r,9as,9br)-6-hydroxy-3,6,9-trimethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,5ah,7h,9ah,9bh-naphtho[1,2-b]furan-2-one
(2e)-3-{[(3as,4r,11ar)-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl]oxy}-2-ethylidene-3-oxopropyl (2z)-2-methylbut-2-enoate
(3s,3ar,4s,6ar,8s,9r,9ar,9br)-4-hydroxy-3,9-dimethyl-6-methylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydroazuleno[4,5-b]furan-2-one
(3r,3as,4s,9r,11ar)-9-hydroxy-3,6,10-trimethyl-4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one
10-hydroxy-1,14,18,18-tetramethyl-7-oxo-2,6-dioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,8,10-trien-17-yl acetate
8-hydroxy-5a,9-dimethyl-3-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-2-one
1,5-dihydroxy-6,6,9a-trimethyl-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-9-yl 3-(4-methoxyphenyl)prop-2-enoate
(3r,3ar,4r,6ar,8s,9r,9ar,9br)-4-hydroxy-3,9-dimethyl-6-methylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydroazuleno[4,5-b]furan-2-one
4'-hydroxy-2'-(hydroxymethyl)-2',4',6'-trimethyl-7'a-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1',3'a-dihydrospiro[cyclopropane-1,5'-inden]-3'-one
(2s,3r,4r,4as,7r,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (4s)-4-hydroxyoctanoate
6-{12-ethyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6-trien-8-yl}-2,4,5-trihydroxyoxan-3-one
(1r,2s,13r,18r)-18-hydroxy-1,2,19,19-tetramethyl-20-oxa-4,16-diazaheptacyclo[13.10.1.0²,¹³.0³,¹¹.0⁵,¹⁰.0¹⁷,²¹.0²²,²⁶]hexacosa-3(11),5,7,9,15,17(21),22(26)-heptaen-23-one
C27H28N2O3 (428.20998180000004)